SUMMARY A retrospective study of 102 cases of Boberg-Ans intraocular lens implantations was conducted. The operations were performed in 3 Birmingham eye units by 5 consultants and 6 surgeons in training. Follow-up ranged from 6 months to 2 years, with a mean of 12-6 months. No cases with adequate follow-up were excluded. When eyes with pre-existing adverse factors were excluded, 87% achieved 6/12 or better. There were no appreciable difference between the results obtained by consultants and those of surgeons in training. The advantages and disadvantages of the lens are discussed.
Implant surgery has advanced steadily over the years and is becoming increasingly performed by ophthalmologists other than specialist implant surgeons. Furthermore it is becoming increasingly important that surgeons undergoing higher surgical training are taught safe implant techniques. Some consultants involved in teaching junior staff consider that, because of the increased risk to the comeal enctothelium during the first few implantations, a posterior chamber intraocular lens has advantages as a 'trainer' lens. Fig. 1 shows a Boberg-Ans lens.
The Boberg-Ans posterior chamber intraocular lens is gaining popularity. It has the advantage of lying posterior to the iris, protecting the comeal endothelium should the anterior chamber be lost. The purpose of this study was to look at the performance of the Boberg-Ans lens, within the limitations of the follow-up period, in the hands of surgeons in training and several experienced ophthalmic surgeons.
Patients and methods
The case notes of 102 consecutive intracapsular cataract extractions and Boberg-Ans implants were studied. There were 100 cases-2 had bilateral surgery. The patients came from the Birmingham and Midland Eye Hospital, Selly Oak Hospital, and East Birmingham Hospital. All eyes with a minimum follow-up of 6 months were included.
METHOD OF OPERATION
A standard intracapsular extraction was performed, usually under general anaesthesia. Alphachymotrypsin and cryoextraction were followed by intraocular lens insertion. Most surgeons preferred to engage the upper loops as a second manoeuvre, working in a closed anterior chamber. Except where specified otherwise, all lenses were sutured to the iris. Postoperative treatment consisted of topical steroid/ antibiotic drops and acetazolomide orally when 646 CF=counting fingers.
required. The patients were seen one to 2 weeks after discharge and at intervals after this by regular ophthalmic staff who were not aware that the study was to be undertaken. Visual acuities used in the study were from refractions done by opticians or junior staff in the various clinics. 
Results
Eyes operated on by consultants numbered 56 (55%) and by surgeons in training 46 (45%). The type of extraction was intracapsular in 99 cases (97%) and unplanned extracapsular in 3 (2-9%). The cataracts were senile in type, and the average age of patients was 73 5 years.
FINAL VISUAL ACUITIES Table 1 shows that without the exclusion of preexisting adverse factors 82 (80%) achieved 6/12 or better in the follow-up period. However, if one excludes pre-existing pathology and one case of postoperative trauma ( Table 2 ) the percentage of cases achieving 6/12 or better rises to 87%. A comparison between cases operated on by consultants and those of surgeons in training can now be made (Table 3) . It can be seen that both groups achieved the same results. Table 4 gives an account of the cases failing to achieve 6/12 or better (where more than one cause is thought to be operating, details are given in the legend).
COMPLICATIONS Operative There were 3 eyes (2 9%) with capsule rupture and 4 eyes with vitreous loss (3-9%). They were managed in conventional manner and all achieved 6/12 or better.
Postoperative (a) Presumed clinical cystoid macular oedema. These were defined as eyes with (1) lowered acuity and a cystoid pattern at the macula on slit-lamp biomicroscopy and/or (2) transient lowered acuity behaving in a manner typical of cystoid macular oedema. This latter group were picked up by following serial visual acuities in the case records. In most of these an attempt was made to visualise the macula, but a cystoid pattern could not be confirmed. relatively short at 6/12 to 2 years (mean 12 6 months), and with time one would expect some of the cases with cystoid macular oedema to improve and perhaps other complications to occur. Sutton3 noted the late presentation of some of the corneal decompensations (the onset of decompensation being delayed for between Il and 44 months in 50% of, cases.) A follow-up study of our group will reveal the incidence of these complications.
It is significant that in our study consultants and surgeons in training achieved virtually the same visual results. But it must be noted that the selection for surgery of cases to be performed by either group was not random: for example some 'high risk cases' may have been selected by the consultants. The 2 papers3'4 studying surgery performed by surgeons in training (quoted above) did not reveal acceptable acuities. It would seem reasonable, therefore, to propose the use of an iris clip posterior chamber lens such as the Boberg-Ans lens as a 'trainer' lens.
A high incidence of transient presumed clinical cystoid macular oedema (15.6%) was discovered. It may be that some of these were recorded as suspect only and could not be proved to be so. Fluorescein angiography was not employed to confirm the diagnosis. However, the number of eyes with clinically significant cystoid oedema at the time of writing is 6 (5.9%). The short follow-up period is relevant in this context. Some factors which may operate in cystoid macular oedema in the Boberg-Ans implantations are as follows. (1) There is occasionally vitreous prolapse around the side of the intraocular lens, which, it is postulated, may cause dynamic traction on the macula. Localised vitreous prolapse was observed in 16 cases (15-7%). However, only 3 cases (2-9%) in this group developed cystoid macular oedema. (2) The solid posterior haptic with its proximity to the ciliary body may cause an inflammatory reaction with vitritis and cystoid macular oedema on an inflammatory basis.
In reviewing 20 authors' incidence of cystoid macular oedema P. Leonard and J. Rommel'7 showed a range of from 0 45% (Pearce) to 15-4% (Sheppard). They felt a 2% incidence of cystoid macular oedema was acceptable.
The absence of any comeal decompensation is encouraging, but must be stated in the light of the follow-up period (6/12 to 2 years). It was not possible to perform comeal endothelial cell counts on the patients in this study.
Loop dislocation. 8-8% of eyes developed loop dislocation. The presence or absence of an iris suture did not appear to predispose to this complication, although we recommend suturing of all Boberg-Ans lenses. Recent figures of loop dislocations in other series are: Schott'8 2-4%, Draeger'9 4-8%, and Jaffe etal. 2 8%.
Hypopyon was recorded in 5 eyes (4-9%). This was in agreement with Hunter,2' who found a 7-5% incidence when eyes were examined routinely at 48 hours on the slit-lamp. It is of interest, however, that he found 15% hypopyons when the condition was diligently sought for. Another 13% with a trace of hypopyon were found. He concluded that these were sterile and settled spontaneously without specific treatment. An exhaustive search for causative factors was fruitless. In one case in our study, although the hypopyon resolved, the acuity reached only 6/18, probably because of a postinflammatory membrane.
CONCLUSION
The Boberg-Ans posterior chamber intraocular lens gives acceptable visual results in the hands of experienced surgeons and surgeons in training alike. There were no eyes with endothelial decompensation within the follow-up period. There was a higher incidence of cystoid macular oedema and loop dislocation than in other series.
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